Physician profile
Fadi Saied
NPI 1013179712
$6,459.65
in general payments reported to CMS, 2019-2025
14 companies · $519 in 2025
The $519 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $1,702 · 2021: $246 · 2022: $1,838 · 2023: $511 · 2024: $325 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,137.31 | 2019-2025 | Mako, T7 |
| Pacira Pharmaceuticals Incorporated | $299.75 | 2023-2025 | Exparel, Zilretta, Iovera |
| Medical Device Business Services, INC. | $264.60 | 2022 | |
| Avanos Medical | $204.83 | 2022-2025 | On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Smith+Nephew, INC. | $153.24 | 2022-2024 | Stravix Pl, Pico 14, Rf20000 |
| Depuy Synthes Sales INC. | $110.60 | 2022 | |
| Heraeus Medical, LLC. | $79.52 | 2021-2023 | Palacos |
| Pacira Therapeutics, INC. | $43.35 | 2020-2021 | |
| Nalu Medical, INC. | $36.52 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $34.48 | 2025 | |
| Bioventus LLC | $27.43 | 2025 | Durolane |
| Becton, Dickinson and Company | $26.96 | 2024 | Arista Ah Flexitip |
| Vericel Corporation | $23.99 | 2021 | |
| Vision Quest Industries INC. | $17.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Saied listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.